Treatment selection for men with metastatic prostate cancer who progress on upfront chemo-hormonal therapy.
Pedro C BarataHamid EmamekhooPrateek MendirattaVadim KoshkinAllison TylerMoshe OrnsteinBrian I RiniTimothy GilliganChristos KyriakopoulosJorge A GarciaPublished in: The Prostate (2018)
For patients with progressive disease on D-ADT, subsequent treatment with a sHT is associated with a longer rPFS and OS.